Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_assertion type Assertion NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_head.
- NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_assertion description "[Moreover, the ex vivo provision of CD40 and IL-21 receptor signals can drive B10-cell development and expansion by four-million-fold, and generate B10 effector cells producing IL-10 that markedly inhibit disease symptoms when transferred into mice with established autoimmune disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_provenance.
- NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_assertion evidence source_evidence_literature NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_provenance.
- NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_assertion SIO_000772 23064231 NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_provenance.
- NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_assertion wasDerivedFrom befree-2016 NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_provenance.
- NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_assertion wasGeneratedBy ECO_0000203 NP1020770.RABcgcTM8xMf_Kf8GAlIkUy799d2xyOA-nk0jkdE1Zw14130_provenance.